First experience of magnetically levitated extracorporeal left ventricular assist device for cardiogenic shock in China.

We report the first case of an investigational maglev extracorporeal ventricular assist device (extra-VAD) use in China for a patient with cardiogenic shock post-coronary artery bypass surgery. There were no extra-VAD devices available for clinical use in China. The patient was successfully supported for 9 days and recovered to hospital discharge. Throughout the support, the patient's haemodynamic and haematologic parameters demonstrated good patient recovery and no device-related complications were observed. Our results encourage extra-VAD use in short-term to mid-term bridging the cardiogenic shock patients in China and potentially other developing countries for both clinical and health economic benefits.